The FDA has approved Bavarian Nordic’s chikungunya vaccine for adolescents and adults, edging out Valneva’s vaccine, which is only approved in people at least 18 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.